基礎から臨床まで:腫瘍の代謝介入と治療におけるメトホルミンの新たな機会

Huiying Lv¹, Haofei Gong¹, Ran Zhao²

¹Henan Key Laboratory of Immunology and Targeted Drugs, School of Medical Technology, Henan Medical University, Xinxiang, China; Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, School of Medical Technology, Henan Medical University, Xinxiang, China; Xinxiang Key Laboratory of Tumor Microenvironment and Immunotherapy, Henan Medical University, Xinxiang, China.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

|September 2, 2025

まとめ

2型糖尿病薬であるメトホルミンは,腫瘍の増殖を抑制し,免疫療法を強化することで,がんの予防と治療に重要な可能性を示しています. 他のがん治療法との相乗効果をさらに研究しています

科学分野:

腫瘍学
代謝医学
免疫療法

背景:

メトホルミンは2型糖尿病の主な治療法です.
最近の研究では,メトホルミンは抗腫瘍性があることが示されています.
そのメカニズムは代謝を超えて腫瘍の成長と免疫反応に影響します

研究の目的:

癌の予防と治療におけるメトホルミンの抗腫瘍能力を検討する.
ガン代謝と抗腫瘍免疫におけるメカニズムを探求する.
腫瘍学における転化の可能性を評価する.

主な方法:

臨床前試験の体系的レビュー
臨床的証拠と現実世界のデータ分析
疫学的な発見の評価

主要な成果:

メトフォーミンは統合されたメカニズムを通して腫瘍の成長と転移を抑制します.
免疫療法に対する感受性を高め,抗がん剤との連携効果を示しています.
臨床データは,乳癌,大腸癌,肝細胞癌などの特定の癌の生存効果とリスク低下を示唆しています.

結論:

メトフォーミンは,がん代謝と免疫におけるプレオトロプ的メカニズムを示しています.
癌治療における代謝免疫学的シナジーにおける重要なエージェントとして有望です
パーソナライズされた腫瘍学的アプローチと新薬投与システムにより治療の応用が拡大しています

キーワード:

免疫代謝メトホルミン治療戦略翻訳医学腫瘍の代謝

さらに関連する動画

06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.1K

10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.3K

関連する概念動画

01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

288

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...

288

02:50

Combination Therapies and Personalized Medicine

5.1K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

5.1K

02:57

Targeted Cancer Therapies

7.8K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

7.8K

01:27

Tumor Immunotherapy

659

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

659

02:56

Treatment Resistant Cancers

3.4K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...